Drug
Docetaxel clinical trials
Also written Taxotere, RP56976, Docefrez and HB1801.
Includes 3 studies of Nanoparticle Albumin-Bound Docetaxel and 3 studies of Liposomal Docetaxel.
- studies test it
- 1,319
- open now
- 111
- in phase 3
- 199
- first study started
- 1993
Keep track of what changes. Save the Docetaxel studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Combined with it in one product
Studies by the year they started
1,314 studies that test it; most in 2004 (100)
| Year | Studies |
|---|---|
| 1993 | 1 |
| 1994 | 1 |
| 1995 | 3 |
| 1996 | 2 |
| 1997 | 11 |
| 1998 | 17 |
| 1999 | 35 |
| 2000 | 27 |
| 2001 | 39 |
| 2002 | 60 |
| 2003 | 78 |
| 2004 | 100 |
| 2005 | 97 |
| 2006 | 74 |
| 2007 | 85 |
| 2008 | 70 |
| 2009 | 48 |
| 2010 | 53 |
| 2011 | 41 |
| 2012 | 30 |
| 2013 | 37 |
| 2014 | 39 |
| 2015 | 38 |
| 2016 | 41 |
| 2017 | 26 |
| 2018 | 39 |
| 2019 | 21 |
| 2020 | 36 |
| 2021 | 33 |
| 2022 | 21 |
| 2023 | 37 |
| 2024 | 26 |
| 2025 | 27 |
| 2026 | 21 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 4
- Phase 1
- 317
- Phase 2
- 904
- Phase 3
- 199
- Phase 4
- 12
- No phase
- 25
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 292 · Other 1,027
Sanofi (50) · M.D. Anderson Cancer Center (33) · National Cancer Institute (NCI) (32) · Dana-Farber Cancer Institute (23) · Alliance for Clinical Trials in Oncology (22) · Hoffmann-La Roche (21) · SWOG Cancer Research Network (20) · Memorial Sloan Kettering Cancer Center (18)
Often tested with
Tested in the same studies.
Cisplatin (201) · Gemcitabine (131) · Carboplatin (130) · Fluorouracil (102) · Capecitabine (96) · Oxaliplatin (84) · Paclitaxel (69) · Cyclophosphamide (68)
Studies
Open first, then newest update. How each study uses Docetaxel is read from its arms, and is right about nine times in ten.
Testing it · 1,319
- PDT For Induction Therapy For Head And Neck CancerRecruitingPhase 2Massachusetts General HospitalNCT07214987Written as Docetaxel
- Measuring Circulating Tumor Deoxyribonucleic Acid Tumor Fraction to Guide Early 177Lu-PSMA-617 Treatment Discontinuation in Patients With Metastatic Castration-Resistant Prostate Cancer, DYNAMO TrialRecruitingPhase 2University of WashingtonNCT07698535Written as Docetaxel
- A Study of Novel Agents or Combinations as Perioperative Treatment in Participants With Locally Advanced Resectable Gastroesophageal AdenocarcinomaRecruitingPhase 2AstraZenecaNCT07069712Written as FLOT Chemotherapy
- A Solid Tumor Study for Long Term Treatment of Cancer Patients Who Participated in Adagrasib StudiesRecruitingPhase 2Mirati Therapeutics Inc.NCT07415031Written as Docetaxel
- In-home Intravesical Chemotherapy for the Treatment of Bladder Cancer, INVITE TrialRecruitingPhase 1/2Mayo ClinicNCT06704191Written as Docetaxel
- NBTXR3, Chemotherapy, and Radiation Therapy for the Treatment of Esophageal CancerRecruitingPhase 1M.D. Anderson Cancer CenterNCT04615013Written as Docetaxel
- RISK-ADAPT Protocol in Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)Not yet recruitingPhase 2Georgetown UniversityNCT07645326Written as Docetaxel
- Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE TrialRecruitingPhase 3Alliance for Clinical Trials in OncologyNCT06931340Written as Docetaxel
- De-Escalated Adjuvant and Definitive Radiation Therapy Informed by DART 2.0 ctHPV-DNARecruitingPhase 2Mayo ClinicNCT05541016Written as Docetaxel
- Preoperative Hypofractionated Radiotherapy With FOLFOX for Esophageal or Gastroesophageal Junction AdenocarcinomaRecruitingPhase 2Mayo ClinicNCT06078709Written as Docetaxel
- A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast CancerRecruitingPhase 2Jazz PharmaceuticalsNCT07102381Written as Docetaxel
- Precise Chemoresection in Low-grade NMIBC Using Drug Screens in Patient-derived OrganoidsNot yet recruitingPhase 2Hospital Centre Biel/BienneNCT06227065Written as Docetaxel
- Immunotherapy With Chemotherapy and Chemoradiation for Advanced Squamous Cancer of Nasal Cavity / Paranasal Sinuses (I-NAPA)RecruitingPhase 2M.D. Anderson Cancer CenterNCT05027633Written as Docetaxel
- A Study of KK2269 in Adult Participants With Solid TumorsRecruitingPhase 1Kyowa Kirin Co., Ltd.NCT06266299Written as Docetaxel
- Retifanlimab (Anti-PD-1 Antibody) With Gemcitabine and Docetaxel in Patients With Advanced Soft Tissue SarcomaRecruitingPhase 1/2Memorial Sloan Kettering Cancer CenterNCT04577014Written as Docetaxel
- A Study of HB1801 Versus Docetaxel (Taxotere®) in Patients With Advanced Breast CancerNot yet recruitingPhase 3CSPC ZhongQi Pharmaceutical Technology Co., Ltd.NCT07805135Written as HB1801
- A Study to Evaluate the Safety and Efficacy of NDV-01 in Participants With NMIBCRecruitingPhase 2Relmada Therapeutics, Inc.NCT06663137Written as NDV01 intravesical controlled release formulation of gemcitabine and docetaxel
- Phase I Study of Docetaxel and 177-Lutetium-PSMA-I&T in First-Line Treatment for Patients With Metastatic Castration-Resistant Prostate AdenocarcinomaRecruitingPhase 1Instituto do Cancer do Estado de São PauloNCT07316686Written as Docetaxel 50mg/m2
- BRE-10: Biomarker Optimization of Neoadjuvant Therapy in Breast CancerRecruitingPhase 2University of Illinois at ChicagoNCT06441890Written as Docetaxel
- Trial Investigating Visugromab and Nivolumab With or Without Docetaxel in 2L Treatment of Participants With Metastatic NSCLCRecruitingPhase 2CatalYm GmbHNCT07246863Written as Docetaxel
See all 1,319 studies that test Docetaxel →
Given in every arm · 480 — Docetaxel is usual care beside what is tested
- Substudy 01A: Safety and Efficacy of Opevesostat (MK-5684)-Based Treatment Combinations or Opevesostat Alone in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-5684-01A)RecruitingPhase 1/2Merck Sharp & Dohme LLCNCT06353386Written as Docetaxel
- Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate CancerRecruitingPhase 1Astellas Pharma Global Development, Inc.NCT05997615Written as Docetaxel
- Phase II Trial of Neoadjuvant Chemotherapy (NAC) Alone or in Combination With Immunotherapy Vaccine PRGN-2009 in Subjects With Newly Diagnosed HPV-Associated Oropharyngeal (Head and Neck) CancerRecruitingPhase 2National Cancer Institute (NCI)NCT06223568Written as Docetaxel
- A Study of Neoadjuvant-adjuvant Durvalumab and FLOT Chemotherapy Followed by Adjuvant Durvalumab in Chinese Patients With Resectable GC/GEJC.Not yet recruitingPhase 3AstraZenecaNCT07877818Written as FLOT Chemotherapy
- A Phase I/II Study of PDS01ADC With Docetaxel and Abiraterone in Adults With Metastatic Castration Sensitive and PDS01ADC With Docetaxel in Castration Resistant Prostate CancerRecruitingPhase 1/2National Cancer Institute (NCI)NCT04633252Written as Docetaxel
- A Study of ASP3082 in Adults With Advanced Solid TumorsRecruitingPhase 1Astellas Pharma IncNCT05382559Written as Docetaxel
- A Study of Pembrolizumab With Trastuzumab and Chemotherapy in People With Esophagogastric CancerRecruitingPhase 2Memorial Sloan Kettering Cancer CenterNCT06123338Written as Docetaxel
- A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)RecruitingPhase 3Merck Sharp & Dohme LLCNCT06952504Written as Docetaxel
- Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)RecruitingPhase 2/3SWOG Cancer Research NetworkNCT06616584Written as Docetaxel
- Phase 1/2 Study Of PARP Inhibition With Olaparib To Enhance The Efficacy Of High-Dose Chemotherapy In Refractory And Relapsed Germ Cell TumorsNot yet recruitingPhase 1/2M.D. Anderson Cancer CenterNCT07850973Written as Docetaxel
- Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid TumorsRecruitingPhase 1ExelixisNCT05176483Written as Docetaxel
- Docetaxel Plus Plinabulin vs Docetaxel Plus Placebo in Advanced/Metastatic Non-Squamous NSCLC After PD-1/PD-L1 Therapy and Platinum Chemotherapy (DUBLIN-4)Not yet recruitingPhase 3BeyondSpring Pharmaceuticals Inc.NCT07361484Written as Docetaxel
- TCb vs EC-T in High Risk ER+/HER2- Breast CancerRecruitingPhase 3Fudan UniversityNCT05901428Written as Docetaxel
- A Trial to Evaluate Intravesical Nadofaragene Firadenovec Alone or in Combination With Chemotherapy or Immunotherapy in Participants With High-grade BCG Unresponsive Non-muscle Invasive Bladder CancerRecruitingPhase 3Ferring PharmaceuticalsNCT06545955Written as Docetaxel
- A Study of Pasritamig (JNJ-78278343) in Combination With Other Agents for Metastatic Prostate CancerRecruitingPhase 1Janssen Research & Development, LLCNCT05818683Written as Docetaxel
- A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate CancerRecruitingPhase 3Janssen Research & Development, LLCNCT07225946Written as Docetaxel
- A Single-Arm Study of QL1706 Combined With DOS as Neoadjuvant Therapy for Locally Advanced Gastric/GEJ AdenocarcinomaNot yet recruitingPhase 2The First Affiliated Hospital of Zhengzhou UniversityNCT07828873Written as Docetaxel
- A Phase II Study of HLX22 in Combination With Trastuzumab and Chemotherapy in HER2-Positive Locally Advanced or Metastatic Breast Cancer PatientsNot yet recruitingPhase 2Shanghai Henlius BiotechNCT07824869Written as Docetaxel
- A Study of HRS-5041 Tablets Combined With Antitumor Therapy in Subjects With Advanced Prostate CancerRecruitingPhase 1/2Jiangsu HengRui Medicine Co., Ltd.NCT06568094Written as Docetaxel Injection
- Neoadjuvant Pyrotinib-to-pertuzumab in HER2+ eBCRecruitingPhase 3Shanghai Jiao Tong University School of MedicineNCT07797218Written as Docetaxel
Showing 20 of 480.
As the comparator · 246 — what is tested is compared with Docetaxel
- Testing the Use of Ado-Trastuzumab Emtansine Compared to the Usual Treatment (Chemotherapy With Docetaxel Plus Trastuzumab) or Trastuzumab Deruxtecan for Recurrent, Metastatic, or Unresectable HER2-Expressing Salivary Gland CancersRecruitingPhase 2NRG OncologyNCT05408845Written as Docetaxel
- Testing the Addition of an Anti-cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (Gemcitabine) for Soft Tissue SarcomaRecruitingPhase 1/2National Cancer Institute (NCI)NCT06498648Written as Docetaxel
- A Study to Compare Setidegrasib (ASP3082) With Docetaxel, in People With Non-small Cell Lung Cancer With a KRAS G12D MutationRecruitingPhase 3Astellas Pharma Global Development, Inc.NCT07566052Written as Docetaxel
- A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate CancerRecruitingPhase 3AmgenNCT07213674Written as Docetaxel
- A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)RecruitingPhase 3AbbVieNCT04928846Written as Docetaxel
- A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)RecruitingPhase 3Merck Sharp & Dohme LLCNCT07419295Written as Docetaxel
- A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine CancerRecruitingPhase 3BioNTech SENCT06340568Written as Docetaxel
- A Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate CancerRecruitingPhase 3BioNTech SENCT07365995Written as Docetaxel
- A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)RecruitingPhase 3Merck Sharp & Dohme LLCNCT06925737Written as Docetaxel
- Phase Ib/II Platform Study of Multiple Anti-Cancer Agents in Participants With Metastatic Prostate CancerRecruitingPhase 1/2AstraZenecaNCT07590934Written as Docetaxel
- DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial CancerRecruitingPhase 3AstraZenecaNCT06989112Written as Docetaxel
- Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic AlterationsRecruitingPhase 3AstraZenecaNCT07291037Written as Docetaxel
- A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02)RecruitingPhase 1/2Merck Sharp & Dohme LLCNCT06863272Written as Docetaxel
- Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate CancerRecruitingPhase 3SWOG Cancer Research NetworkNCT03678025Written as Docetaxel
- A Study to Test Inavolisib Treatment in Participants With Metastatic Castration-Resistant Prostate CancerRecruitingPhase 2Hoffmann-La RocheNCT07287150Written as Docetaxel
- A Study to Evaluate CRB-701 Compared to Investigator's Choice Therapy in Previously Treated Oropharyngeal Squamous Cell CarcinomaRecruitingPhase 3Corbus Pharmaceuticals Inc.NCT07768189Written as Docetaxel
- Substudy 01I: A Study of Investigational Agents in Participants With Previously Treated Stage IV Squamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01I/KEYMAKER-U01I)RecruitingPhase 2Merck Sharp & Dohme LLCNCT06780098Written as Docetaxel
- A Study to Assess Intravenous (IV) Telisotuzumab Adizutecan Compared to Standard of Care in Adult Participants Previously Treated, EGFR Wildtype, Locally Advanced/Metastatic Non-Squamous Non-Small Cell Lung CancerNot yet recruitingPhase 3AbbVieNCT07821684Written as Docetaxel
- A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitecan-hziy Versus Standard of Care in the Treatment of Advanced Urothelial CancerRecruitingPhase 3National Cancer Institute (NCI)NCT06524544Written as Docetaxel
- A Study to Learn About the Investigational Drug Rinzimetostat (ORIC-944) in Patients With mCRPC Who Were Previously Treated With Abiraterone Acetate (Himalayas-1)RecruitingPhase 3ORIC PharmaceuticalsNCT07723248Written as Docetaxel
Showing 20 of 246.
Codes
What other systems call Docetaxel · ClinicalTrials.gg INT006647
- MeSH (NLM) D000077143DocetaxelConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 15H5577CQDDOCETAXELConfirmed FDA, NLM, Wikidata
- RxNorm 72962Confirmed FDA, Wikidata
- Wikidata Q27126905docetaxel trihydrateConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C1526DocetaxelConfirmed FDA, Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D000077143 | Docetaxel | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 15H5577CQD | DOCETAXEL | Confirmed FDA, NLM, Wikidata |
| RxNorm | 72962 | — | Confirmed FDA, Wikidata |
| Wikidata | Q27126905 | docetaxel trihydrate | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C1526 | Docetaxel | Confirmed FDA, Wikidata |
Also registered as docetaxel anhydrous (UNII 699121PHCA · RxNorm 1299922).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.